Why One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/8b/d8/2c/8bd82cd0-3947-274e-acd6-e4ff775680b4/mza_16519413190149644398.jpg/600x600bb.jpg

BioTech Nation ... with Dr. Moira Gunn

Moira Gunn

128 episodes

6 days ago

Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.

All content for BioTech Nation ... with Dr. Moira Gunn is the property of Moira Gunn and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Why One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals

BioTech Nation ... with Dr. Moira Gunn

19 minutes

4 months ago

Why One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals

This week on BioTech Nation, Catalyst Pharmaceuticals CEO Rich Daly discusses the complexities of treating epilepsy and rare diseases. From the challenges of polypharmacy—where patients need multiple drugs to manage a single condition—to the hurdles of diagnosing and treating ultra-rare diseases.